Filter

121-130 of 374 results

  • The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

    From Drew Altman

    In a new “Beyond the Data” column, KFF’s President and CEO Dr. Drew Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for…

  • How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?

    Quick Insights

    Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.

  • Racial Disparities in COVID-19 Impacts and Vaccinations for Children

    Issue Brief

    COVID-19 has disproportionately negatively affected the physical and mental health, academic growth, and economic security of children of color. At the same time, the limited data available to date suggest some children of color may be less likely to receive a COVID-19 vaccine, leaving them at elevated risk as the virus continues to spread and as many return to in-person school.

  • COVID-19 Vaccine Access for People with Disabilities

    Issue Brief

    This issue brief presents current state-level data about COVID-19 cases and deaths in settings that primarily serve nonelderly people with disabilities and summarizes available research on this population’s elevated risk of severe illness and death; explains how nonelderly people with disabilities and their LTSS providers are reflected in state vaccine prioritization plans; and discusses key issues related to vaccine access for these populations.

  • Measles Elimination Status: What It Is and How the U.S. Could Lose It

    Policy Watch

    This policy watch examines the United States’ measles elimination status, including what it means to eliminate measles, whether the current measles outbreak could threaten the country’s measles elimination status, and what losing that status might mean for measles control.